Effect of an injectable trace mineral supplement on the immune response of dairy calves.


Journal

Research in veterinary science
ISSN: 1532-2661
Titre abrégé: Res Vet Sci
Pays: England
ID NLM: 0401300

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 12 06 2019
revised: 18 12 2019
accepted: 12 02 2020
pubmed: 28 2 2020
medline: 4 9 2020
entrez: 28 2 2020
Statut: ppublish

Résumé

On a spring calving, pastoral dairy farm, the first 40 heifer calves born after calving mid-point (50% of the herd calved) were blood sampled within 24 h. Thirty were selected, using stratified randomisation to form two equal groups (treatment and control) with the same distribution of serum total protein, copper, selenium, zinc, and manganese concentrations, age and breed. From the remaining 10 calves, five were randomly selected into a sentinel group to assess field exposure to Salmonella spp. All calves received two injections of a killed vaccine containing Salmonella spp. antigens at 2 and 6 weeks of age. Concurrently, the treatment group were injected with 1 mL/50 kg trace mineral supplement (TMS) containing 40 mg zinc, 10 mg manganese, 5 mg selenium, 15 mg copper per mL. Sentinel animals received no injections. All animals were bled from 2 to 9 weeks for assay of immune function. At three and four weeks, white blood cells from TMS calves had an increased percentage of cells phagocytosing (effect size = 9.36 and 4.35) and increased number of bacteria ingested per cell (effect size = 0.93 and 1.52). No differences were detected in gamma interferon response (effect size <0.15) or Salmonella sp. antibody titres (effect size <0.20).

Identifiants

pubmed: 32105948
pii: S0034-5288(19)30595-8
doi: 10.1016/j.rvsc.2020.02.007
pii:
doi:

Substances chimiques

Antigens, Bacterial 0
Trace Elements 0
Vaccines, Inactivated 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Andrew Bates (A)

Vetlife NZ, Vetlife Scientific, 1, Waitohi-Temuka Road, Temuka, New Zealand. Electronic address: andrew.bates@vetlife.co.nz.

Matt Wells (M)

Virbac New Zealand Ltd, 26-30 Maui Street, Pukete, Hamilton 3200, New Zealand.

Richard Laven (R)

School of Veterinary Sciences, Massey University, New Zealand.

Line Ferriman (L)

Vetlife Ashburton, 4, Seafield Road, Ashburton 7700, PO Box 161, New Zealand.

Axel Heiser (A)

AgResearch, Hopkirk Research Institute, AgResearch, Palmerston North, New Zealand.

Clare Fitzpatrick (C)

Department of Microbiology and Immunology, University of Otago, New Zealand.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH